Page results
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5- 8 patient information leaflet
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2024/0259 - Clinical attachments for international medical graduates
-
FOI/2024/0263 - Longest wait for ophthalmology pathway treatment
-
FOI/2024/0268 - Module on imaging offered to PAs as training in requesting ionising radiation
-
FOI/2024/0269 - Paediatric audiology services
-
FOI/2024/0273 - Covid restrictions for visitors at Elizabeth Garret Anderson (EGA) from December 2021-June 2022
-
FOI/2024/0274 - Number of endoscopes at Trust
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification